Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Cerchione

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Scientific Reports|November 5, 2025
First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19Sara Bravaccini, Fabio Nicolini, William Balzi, et al.
Anti-Cancer Drugs|October 22, 2019
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemiaClaudio Cerchione, Giovanni Martinelli, Silvana Pedatella, et al.
Cell Biology and Toxicology|September 14, 2021
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cellsAndrea Ghelli Luserna Di Rorà, Martina Ghetti, Lorenzo Ledda, et al.
Minerva Medica|September 21, 2020
FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectivesAdrián Mosquera Orgueira, Laura Bao Pérez, Alicia Mosquera Torre, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Frontiers in Oncology|January 27, 2022
Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based ModelsAdrián Mosquera Orgueira, Miguel Cid López, Andrés Peleteiro Raíndo, et al.
Frontiers in Immunology|October 27, 2025
Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patientsFabio Nicolini, Anna Gaimari, Lucia Mazzotti, et al.
Leukemia|May 4, 2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Plos One|February 16, 2021
Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemiaAdrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, et al.
Frontiers in Oncology|April 15, 2021
Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression ProfilingAdrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Scientific Reports|November 5, 2025
First real-world evidence from the Emilia-Romagna region suggests tamoxifen protects breast cancer patients from COVID-19Sara Bravaccini, Fabio Nicolini, William Balzi, et al.
Anti-Cancer Drugs|October 22, 2019
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemiaClaudio Cerchione, Giovanni Martinelli, Silvana Pedatella, et al.
Cell Biology and Toxicology|September 14, 2021
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cellsAndrea Ghelli Luserna Di Rorà, Martina Ghetti, Lorenzo Ledda, et al.
Minerva Medica|September 21, 2020
FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectivesAdrián Mosquera Orgueira, Laura Bao Pérez, Alicia Mosquera Torre, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Frontiers in Oncology|January 27, 2022
Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based ModelsAdrián Mosquera Orgueira, Miguel Cid López, Andrés Peleteiro Raíndo, et al.
Frontiers in Immunology|October 27, 2025
Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patientsFabio Nicolini, Anna Gaimari, Lucia Mazzotti, et al.
Leukemia|May 4, 2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Plos One|February 16, 2021
Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemiaAdrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, et al.
Frontiers in Oncology|April 15, 2021
Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression ProfilingAdrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, et al.
Pageof 13